These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 32573961)

  • 1. Mesenchymal stem cells as a multimodal treatment for nervous system diseases.
    Badyra B; Sułkowski M; Milczarek O; Majka M
    Stem Cells Transl Med; 2020 Oct; 9(10):1174-1189. PubMed ID: 32573961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells: new approaches for the treatment of neurological diseases.
    Momin EN; Mohyeldin A; Zaidi HA; Vela G; Quiñones-Hinojosa A
    Curr Stem Cell Res Ther; 2010 Dec; 5(4):326-44. PubMed ID: 20528757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotherapy using stromal cells: Current and advance multi-treatment approaches.
    Shende P; Gupta H; Gaud RS
    Biomed Pharmacother; 2018 Jan; 97():38-44. PubMed ID: 29080456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MSC-Based Cell Therapy in Neurological Diseases: A Concise Review of the Literature in Pre-Clinical and Clinical Research.
    Zhang X; Kuang Q; Xu J; Lin Q; Chi H; Yu D
    Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stem Cells for Neurological Disorders.
    Andrzejewska A; Dabrowska S; Lukomska B; Janowski M
    Adv Sci (Weinh); 2021 Apr; 8(7):2002944. PubMed ID: 33854883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.
    Harrell CR; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
    Cells; 2019 May; 8(5):. PubMed ID: 31100966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders.
    Kahmini FR; Shahgaldi S
    Exp Mol Pathol; 2021 Feb; 118():104566. PubMed ID: 33160961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Advancement in Neuronal Transdifferentiation of Mesenchymal Stromal Cells for Neurological Disorders.
    Choudhary P; Gupta A; Singh S
    J Mol Neurosci; 2021 May; 71(5):889-901. PubMed ID: 33047251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Modification of Mesenchymal Stem Cells for Neurological Disease Therapy: What Effects Does it Have on Phenotype/Cell Behavior, Determining Their Effectiveness?
    Ebrahim N; James V; Rizvanov AA; Mukhamedshina Y
    Mol Diagn Ther; 2020 Dec; 24(6):683-702. PubMed ID: 32926348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine.
    Carvalho MM; Teixeira FG; Reis RL; Sousa N; Salgado AJ
    Curr Stem Cell Res Ther; 2011 Sep; 6(3):221-8. PubMed ID: 21476975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine.
    Miceli V; Bulati M; Iannolo G; Zito G; Gallo A; Conaldi PG
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system.
    Phinney DG; Isakova I
    Curr Pharm Des; 2005; 11(10):1255-65. PubMed ID: 15853682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing Mesenchymal Stem Cell Therapy with CRISPR/Cas9 for Clinical Trial Studies.
    Golchin A; Shams F; Karami F
    Adv Exp Med Biol; 2020; 1247():89-100. PubMed ID: 31974923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke.
    Cunningham CJ; Redondo-Castro E; Allan SM
    J Cereb Blood Flow Metab; 2018 Aug; 38(8):1276-1292. PubMed ID: 29768965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration.
    Lin H; Chen H; Zhao X; Chen Z; Zhang P; Tian Y; Wang Y; Ding T; Wang L; Shen Y
    J Transl Med; 2021 Nov; 19(1):456. PubMed ID: 34736500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through "pharmaceuticalization" for the best formulation.
    Bari E; Ferrarotti I; Torre ML; Corsico AG; Perteghella S
    J Control Release; 2019 Sep; 309():11-24. PubMed ID: 31326462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?
    Teixeira FG; Carvalho MM; Sousa N; Salgado AJ
    Cell Mol Life Sci; 2013 Oct; 70(20):3871-82. PubMed ID: 23456256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.
    Redondo-Castro E; Cunningham CJ; Miller J; Brown H; Allan SM; Pinteaux E
    Stem Cell Res Ther; 2018 Jan; 9(1):11. PubMed ID: 29343288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regenerative Potential of Mesenchymal Stem Cells' (MSCs) Secretome for Liver Fibrosis Therapies.
    Nazarie Ignat SR; Gharbia S; Hermenean A; Dinescu S; Costache M
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning.
    Ferreira JR; Teixeira GQ; Santos SG; Barbosa MA; Almeida-Porada G; Gonçalves RM
    Front Immunol; 2018; 9():2837. PubMed ID: 30564236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.